Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      A National Steering Committee constituted to initiate a Scientific Validation, Research

      A National Steering Committee constituted to initiate a Scientific Validation, Research

      Ruby Khatun Khatun2 Aug 2017 9:22 AM IST
      The Department of Science and Technology (DST), Government of India has constituted a National Steering Committee to initiate a National Programme on...
      Sanofi raises outlook but key eczema drug disappoints investors

      Sanofi raises outlook but key eczema drug disappoints investors

      Ruby Khatun Khatun2 Aug 2017 9:20 AM IST
      PARIS: Sanofi raised its 2017 earnings forecast on the back of strong growth in the second quarter but investors were disappointed with sales of key...
      AstraZeneca lung cancer failure sparks 16 percent share fall

      AstraZeneca lung cancer failure sparks 16 percent share fall

      Ruby Khatun Khatun2 Aug 2017 9:18 AM IST
      LONDON: AstraZeneca's combination of two injectable immunotherapy drugs failed to help patients as hoped in a closely watched advanced lung cancer...
      AbbVie to remain cautious on drug pricing, shares fall

      AbbVie to remain cautious on drug pricing, shares fall

      Ruby Khatun Khatun2 Aug 2017 9:15 AM IST
      AbbVie Inc's said it would be cautious with drug pricing, especially for Humira, the world's biggest selling drug, sending its shares down 2 percent,...
      GSK gives up on rare diseases as gene therapy gets two customers

      GSK gives up on rare diseases as gene therapy gets two customers

      Ruby Khatun Khatun2 Aug 2017 9:14 AM IST
      LONDON: GlaxoSmithKline (GSK) is swimming against the tide by getting out of treatments for rare diseases at a time when rivals like Sanofi and Shire...
      Govt set to block Chinese takeover of Gland Pharma: Report

      Govt set to block Chinese takeover of Gland Pharma: Report

      Ruby Khatun Khatun1 Aug 2017 11:30 AM IST
      India has privately raised objections to Chinese firm Shanghai Fosun Pharmaceutical Group's proposed $1.3 billion takeover of Indian drugmaker Gland...
      Fortis Healthcare appoints Ajey Maharaj as Head - Corporate Communications

      Fortis Healthcare appoints Ajey Maharaj as Head - Corporate Communications

      Ruby Khatun Khatun1 Aug 2017 10:00 AM IST
      New Delhi: Fortis Healthcare has announced the appointment of Ajey Maharaj as Head, Corporate Communications. Ajey will succeed Raghunanadan Kochar...
      Wysa raises 1.3 million dollar seed funding by Kae Capital and Angel Investors 

      Wysa raises 1.3 million dollar seed funding by Kae Capital and Angel Investors 

      Ruby Khatun Khatun1 Aug 2017 9:30 AM IST
      Bengaluru: The two early stage investment firms Kae Capital and Angel Investors has invested $1.3 million seed funding in Wysa.Wysa, a mental health...
      Merck says cyber attack halted production, will hurt profits

      Merck says cyber attack halted production, will hurt profits

      Ruby Khatun Khatun1 Aug 2017 9:30 AM IST
      NEW YORK/LAS VEGAS: Drug and vaccine maker Merck & Co Inc said it suffered a worldwide disruption of its operations when it was the victim of an...
      Johnson & Johnson Announces Encouraging First-in-Human Clinical Data for Investigational HIV Preventive Vaccine

      Johnson & Johnson Announces Encouraging First-in-Human Clinical Data for Investigational HIV Preventive Vaccine

      Ruby Khatun Khatun1 Aug 2017 9:30 AM IST
      Paris, France: Johnson & Johnson announced encouraging first-in-human clinical data for an investigational HIV-1 vaccine regimen in development at...
      Roche leukaemia drug gets FDA breakthrough therapy designation

      Roche leukaemia drug gets FDA breakthrough therapy designation

      Ruby Khatun Khatun1 Aug 2017 9:28 AM IST
      ZURICH: Roche Holding AG's Venclexta has won breakthrough therapy designation in acute myeloid leukaemia (AML) from the U.S. Food and Drug...
      FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death

      FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death

      Ruby Khatun Khatun1 Aug 2017 9:20 AM IST
      The U.S. Food and Drug Administration (FDA) announced a new comprehensive plan for tobacco and nicotine regulation that will serve as a multi-year...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok